Laddar...

A robust prognostic gene expression signature for early stage lung adenocarcinoma

BACKGROUND: Stage I lung adenocarcinoma is usually not treated with adjuvant chemotherapy; however, around half of these patients do not survive 5 years. Therefore, a reliable prognostic biomarker for early stage patients would be critical to identify those most likely to benefit from early addition...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Biomark Res
Huvudupphovsmän: Krzystanek, Marcin, Moldvay, Judit, Szüts, David, Szallasi, Zoltan, Eklund, Aron Charles
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2016
Ämnen:
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4761211/
https://ncbi.nlm.nih.gov/pubmed/26900477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-016-0058-3
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!